APO Research
Talk to an analyst

APO RESEARCH · REPORT

Praziquantel

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Praziquantel Market Analysis and Forecast 2026-2032

19 December 2025204 pages

Choose your research edition.

Industry ResearchPraziquantel Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Praziquantel Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Praziquantel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Praziquantel Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Praziquantel Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Praziquantel market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Praziquantel is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Praziquantel is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Praziquantel is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Praziquantel is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Praziquantel include Zoetis, Merck, Bayer, Soparfin, Shin Poong Pharm, Richter Pharma, Norbrook Laboratories, Merial and Mavlab Animal Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Praziquantel, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Praziquantel, also provides the sales of main regions and countries. Of the upcoming market potential for Praziquantel, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Praziquantel sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Praziquantel market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Praziquantel sales, projected growth trends, production technology, application and end-user industry.

Praziquantel Segment by Company

Zoetis

Merck

Bayer

Soparfin

Shin Poong Pharm

Richter Pharma

Norbrook Laboratories

Merial

Mavlab Animal Health

Lavet Pharmaceuticals

Kyron Pharma

Krka

Ecuphar

Covetrus

CiplaVet

Chanelle Pharma

Ceva Santé Animale

C and H Generics

Auvex

AniMedica

Praziquantel Segment by Type

Patent

Generic

Praziquantel Segment by Application

Liver Fluke Infection

Cysticercosis

Cestode Infections

Trematode Infections

Schistosoma Infection

Others

Praziquantel Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Praziquantel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Praziquantel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Praziquantel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Praziquantel in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Praziquantel manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Praziquantel sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Praziquantel Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Patent Major Manufacturers Table 3. Generic Major Manufacturers Table 4. Global Praziquantel Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Liver Fluke Infection Major Manufacturers Table 6. Cysticercosis Major Manufacturers Table 7. Cestode Infections Major Manufacturers Table 8. Trematode Infections Major Manufacturers Table 9. Schistosoma Infection Major Manufacturers Table 10. Others Major Manufacturers Table 11. Praziquantel Industry Trends Table 12. Praziquantel Industry Drivers Table 13. Praziquantel Industry Opportunities and Challenges Table 14. Praziquantel Industry Restraints Table 15. Global Praziquantel Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Praziquantel Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Praziquantel Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Praziquantel Revenue Market Share by Region (2021-2026) Table 19. Global Praziquantel Revenue Market Share by Region (2027-2032) Table 20. Global Praziquantel Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Praziquantel Sales by Region (2021-2026) & (K Units) Table 22. Global Praziquantel Sales by Region (2027-2032) & (K Units) Table 23. Global Praziquantel Sales Market Share by Region (2021-2026) Table 24. Global Praziquantel Sales Market Share by Region (2027-2032) Table 25. Global Praziquantel Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Praziquantel Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Praziquantel Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Praziquantel Sales Market Share by Manufacturers (2021-2026) Table 29. Global Praziquantel Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Praziquantel Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Praziquantel Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Praziquantel Manufacturers, Product Type & Application Table 33. Global Praziquantel Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Praziquantel by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Praziquantel Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Praziquantel Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Praziquantel Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Praziquantel Revenue Market Share by Type (2021-2026) Table 40. Global Praziquantel Revenue Market Share by Type (2027-2032) Table 41. Global Praziquantel Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Praziquantel Sales by Type (2021-2026) & (K Units) Table 43. Global Praziquantel Sales by Type (2027-2032) & (K Units) Table 44. Global Praziquantel Sales Market Share by Type (2021-2026) Table 45. Global Praziquantel Sales Market Share by Type (2027-2032) Table 46. Global Praziquantel Price by Type (2021-2026) & (US$/Unit) Table 47. Global Praziquantel Price by Type (2027-2032) & (US$/Unit) Table 48. Global Praziquantel Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Praziquantel Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Praziquantel Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Praziquantel Revenue Market Share by Application (2021-2026) Table 52. Global Praziquantel Revenue Market Share by Application (2027-2032) Table 53. Global Praziquantel Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Praziquantel Sales by Application (2021-2026) & (K Units) Table 55. Global Praziquantel Sales by Application (2027-2032) & (K Units) Table 56. Global Praziquantel Sales Market Share by Application (2021-2026) Table 57. Global Praziquantel Sales Market Share by Application (2027-2032) Table 58. Global Praziquantel Price by Application (2021-2026) & (US$/Unit) Table 59. Global Praziquantel Price by Application (2027-2032) & (US$/Unit) Table 60. Zoetis Company Information Table 61. Zoetis Business Overview Table 62. Zoetis Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Zoetis Praziquantel Product Portfolio Table 64. Zoetis Recent Development Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Merck Praziquantel Product Portfolio Table 69. Merck Recent Development Table 70. Bayer Company Information Table 71. Bayer Business Overview Table 72. Bayer Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Bayer Praziquantel Product Portfolio Table 74. Bayer Recent Development Table 75. Soparfin Company Information Table 76. Soparfin Business Overview Table 77. Soparfin Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Soparfin Praziquantel Product Portfolio Table 79. Soparfin Recent Development Table 80. Shin Poong Pharm Company Information Table 81. Shin Poong Pharm Business Overview Table 82. Shin Poong Pharm Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Shin Poong Pharm Praziquantel Product Portfolio Table 84. Shin Poong Pharm Recent Development Table 85. Richter Pharma Company Information Table 86. Richter Pharma Business Overview Table 87. Richter Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Richter Pharma Praziquantel Product Portfolio Table 89. Richter Pharma Recent Development Table 90. Norbrook Laboratories Company Information Table 91. Norbrook Laboratories Business Overview Table 92. Norbrook Laboratories Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Norbrook Laboratories Praziquantel Product Portfolio Table 94. Norbrook Laboratories Recent Development Table 95. Merial Company Information Table 96. Merial Business Overview Table 97. Merial Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Merial Praziquantel Product Portfolio Table 99. Merial Recent Development Table 100. Mavlab Animal Health Company Information Table 101. Mavlab Animal Health Business Overview Table 102. Mavlab Animal Health Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Mavlab Animal Health Praziquantel Product Portfolio Table 104. Mavlab Animal Health Recent Development Table 105. Lavet Pharmaceuticals Company Information Table 106. Lavet Pharmaceuticals Business Overview Table 107. Lavet Pharmaceuticals Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Lavet Pharmaceuticals Praziquantel Product Portfolio Table 109. Lavet Pharmaceuticals Recent Development Table 110. Kyron Pharma Company Information Table 111. Kyron Pharma Business Overview Table 112. Kyron Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Kyron Pharma Praziquantel Product Portfolio Table 114. Kyron Pharma Recent Development Table 115. Krka Company Information Table 116. Krka Business Overview Table 117. Krka Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Krka Praziquantel Product Portfolio Table 119. Krka Recent Development Table 120. Ecuphar Company Information Table 121. Ecuphar Business Overview Table 122. Ecuphar Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Ecuphar Praziquantel Product Portfolio Table 124. Ecuphar Recent Development Table 125. Covetrus Company Information Table 126. Covetrus Business Overview Table 127. Covetrus Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Covetrus Praziquantel Product Portfolio Table 129. Covetrus Recent Development Table 130. CiplaVet Company Information Table 131. CiplaVet Business Overview Table 132. CiplaVet Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. CiplaVet Praziquantel Product Portfolio Table 134. CiplaVet Recent Development Table 135. Chanelle Pharma Company Information Table 136. Chanelle Pharma Business Overview Table 137. Chanelle Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Chanelle Pharma Praziquantel Product Portfolio Table 139. Chanelle Pharma Recent Development Table 140. Ceva Santé Animale Company Information Table 141. Ceva Santé Animale Business Overview Table 142. Ceva Santé Animale Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Ceva Santé Animale Praziquantel Product Portfolio Table 144. Ceva Santé Animale Recent Development Table 145. C and H Generics Company Information Table 146. C and H Generics Business Overview Table 147. C and H Generics Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. C and H Generics Praziquantel Product Portfolio Table 149. C and H Generics Recent Development Table 150. Auvex Company Information Table 151. Auvex Business Overview Table 152. Auvex Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Auvex Praziquantel Product Portfolio Table 154. Auvex Recent Development Table 155. AniMedica Company Information Table 156. AniMedica Business Overview Table 157. AniMedica Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. AniMedica Praziquantel Product Portfolio Table 159. AniMedica Recent Development Table 160. North America Praziquantel Revenue by Type (2021-2026) & (US$ Million) Table 161. North America Praziquantel Revenue by Type (2027-2032) & (US$ Million) Table 162. North America Praziquantel Sales by Type (2021-2026) & (K Units) Table 163. North America Praziquantel Sales by Type (2027-2032) & (K Units) Table 164. North America Praziquantel Sales Price by Type (2021-2026) & (US$/Unit) Table 165. North America Praziquantel Sales Price by Type (2027-2032) & (US$/Unit) Table 166. North America Praziquantel Revenue by Application (2021-2026) & (US$ Million) Table 167. North America Praziquantel Revenue by Application (2027-2032) & (US$ Million) Table 168. North America Praziquantel Sales by Application (2021-2026) & (K Units) Table 169. North America Praziquantel Sales by Application (2027-2032) & (K Units) Table 170. North America Praziquantel Sales Price by Application (2021-2026) & (US$/Unit) Table 171. North America Praziquantel Sales Price by Application (2027-2032) & (US$/Unit) Table 172. North America Praziquantel Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. North America Praziquantel Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. North America Praziquantel Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. North America Praziquantel Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 176. North America Praziquantel Sales by Country (2021-2026) & (K Units) Table 177. North America Praziquantel Sales by Country (2027-2032) & (K Units) Table 178. North America Praziquantel Sales Price by Country (2021-2026) & (US$/Unit) Table 179. North America Praziquantel Sales Price by Country (2027-2032) & (US$/Unit) Table 180. United States Praziquantel Revenue (2021-2032) & (US$ Million) Table 181. Canada Praziquantel Revenue (2021-2032) & (US$ Million) Table 182. Europe Praziquantel Revenue by Type (2021-2026) & (US$ Million) Table 183. Europe Praziquantel Revenue by Type (2027-2032) & (US$ Million) Table 184. Europe Praziquantel Sales by Type (2021-2026) & (K Units) Table 185. Europe Praziquantel Sales by Type (2027-2032) & (K Units) Table 186. Europe Praziquantel Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Europe Praziquantel Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Europe Praziquantel Revenue by Application (2021-2026) & (US$ Million) Table 189. Europe Praziquantel Revenue by Application (2027-2032) & (US$ Million) Table 190. Europe Praziquantel Sales by Application (2021-2026) & (K Units) Table 191. Europe Praziquantel Sales by Application (2027-2032) & (K Units) Table 192. Europe Praziquantel Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Europe Praziquantel Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Europe Praziquantel Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Europe Praziquantel Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Europe Praziquantel Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Europe Praziquantel Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Europe Praziquantel Sales by Country (2021-2026) & (K Units) Table 199. Europe Praziquantel Sales by Country (2027-2032) & (K Units) Table 200. Europe Praziquantel Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Europe Praziquantel Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Germany Praziquantel Revenue (2021-2032) & (US$ Million) Table 203. France Praziquantel Revenue (2021-2032) & (US$ Million) Table 204. U.K. Praziquantel Revenue (2021-2032) & (US$ Million) Table 205. Italy Praziquantel Revenue (2021-2032) & (US$ Million) Table 206. Netherlands Praziquantel Revenue (2021-2032) & (US$ Million) Table 207. China Praziquantel Revenue by Type (2021-2026) & (US$ Million) Table 208. China Praziquantel Revenue by Type (2027-2032) & (US$ Million) Table 209. China Praziquantel Sales by Type (2021-2026) & (K Units) Table 210. China Praziquantel Sales by Type (2027-2032) & (K Units) Table 211. China Praziquantel Sales Price by Type (2021-2026) & (US$/Unit) Table 212. China Praziquantel Sales Price by Type (2027-2032) & (US$/Unit) Table 213. China Praziquantel Revenue by Application (2021-2026) & (US$ Million) Table 214. China Praziquantel Revenue by Application (2027-2032) & (US$ Million) Table 215. China Praziquantel Sales by Application (2021-2026) & (K Units) Table 216. China Praziquantel Sales by Application (2027-2032) & (K Units) Table 217. China Praziquantel Sales Price by Application (2021-2026) & (US$/Unit) Table 218. China Praziquantel Sales Price by Application (2027-2032) & (US$/Unit) Table 219. Asia Praziquantel Revenue by Type (2021-2026) & (US$ Million) Table 220. Asia Praziquantel Revenue by Type (2027-2032) & (US$ Million) Table 221. Asia Praziquantel Sales by Type (2021-2026) & (K Units) Table 222. Asia Praziquantel Sales by Type (2027-2032) & (K Units) Table 223. Asia Praziquantel Sales Price by Type (2021-2026) & (US$/Unit) Table 224. Asia Praziquantel Sales Price by Type (2027-2032) & (US$/Unit) Table 225. Asia Praziquantel Revenue by Application (2021-2026) & (US$ Million) Table 226. Asia Praziquantel Revenue by Application (2027-2032) & (US$ Million) Table 227. Asia Praziquantel Sales by Application (2021-2026) & (K Units) Table 228. Asia Praziquantel Sales by Application (2027-2032) & (K Units) Table 229. Asia Praziquantel Sales Price by Application (2021-2026) & (US$/Unit) Table 230. Asia Praziquantel Sales Price by Application (2027-2032) & (US$/Unit) Table 231. Asia Praziquantel Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. Asia Praziquantel Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. Asia Praziquantel Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. Asia Praziquantel Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 235. Asia Praziquantel Sales by Country (2021-2026) & (K Units) Table 236. Asia Praziquantel Sales by Country (2027-2032) & (K Units) Table 237. Asia Praziquantel Sales Price by Country (2021-2026) & (US$/Unit) Table 238. Asia Praziquantel Sales Price by Country (2027-2032) & (US$/Unit) Table 239. Japan Praziquantel Revenue (2021-2032) & (US$ Million) Table 240. South Korea Praziquantel Revenue (2021-2032) & (US$ Million) Table 241. India Praziquantel Revenue (2021-2032) & (US$ Million) Table 242. Australia Praziquantel Revenue (2021-2032) & (US$ Million) Table 243. China Taiwan Praziquantel Revenue (2021-2032) & (US$ Million) Table 244. Southeast Asia Praziquantel Revenue (2021-2032) & (US$ Million) Table 245. SAMEA Praziquantel Revenue by Type (2021-2026) & (US$ Million) Table 246. SAMEA Praziquantel Revenue by Type (2027-2032) & (US$ Million) Table 247. SAMEA Praziquantel Sales by Type (2021-2026) & (K Units) Table 248. SAMEA Praziquantel Sales by Type (2027-2032) & (K Units) Table 249. SAMEA Praziquantel Sales Price by Type (2021-2026) & (US$/Unit) Table 250. SAMEA Praziquantel Sales Price by Type (2027-2032) & (US$/Unit) Table 251. SAMEA Praziquantel Revenue by Application (2021-2026) & (US$ Million) Table 252. SAMEA Praziquantel Revenue by Application (2027-2032) & (US$ Million) Table 253. SAMEA Praziquantel Sales by Application (2021-2026) & (K Units) Table 254. SAMEA Praziquantel Sales by Application (2027-2032) & (K Units) Table 255. SAMEA Praziquantel Sales Price by Application (2021-2026) & (US$/Unit) Table 256. SAMEA Praziquantel Sales Price by Application (2027-2032) & (US$/Unit) Table 257. SAMEA Praziquantel Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 258. SAMEA Praziquantel Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 259. SAMEA Praziquantel Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 260. SAMEA Praziquantel Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 261. SAMEA Praziquantel Sales by Country (2021-2026) & (K Units) Table 262. SAMEA Praziquantel Sales by Country (2027-2032) & (K Units) Table 263. SAMEA Praziquantel Sales Price by Country (2021-2026) & (US$/Unit) Table 264. SAMEA Praziquantel Sales Price by Country (2027-2032) & (US$/Unit) Table 265. Brazil Praziquantel Revenue (2021-2032) & (US$ Million) Table 266. Argentina Praziquantel Revenue (2021-2032) & (US$ Million) Table 267. Chile Praziquantel Revenue (2021-2032) & (US$ Million) Table 268. Colombia Praziquantel Revenue (2021-2032) & (US$ Million) Table 269. Peru Praziquantel Revenue (2021-2032) & (US$ Million) Table 270. Saudi Arabia Praziquantel Revenue (2021-2032) & (US$ Million) Table 271. Israel Praziquantel Revenue (2021-2032) & (US$ Million) Table 272. UAE Praziquantel Revenue (2021-2032) & (US$ Million) Table 273. Turkey Praziquantel Revenue (2021-2032) & (US$ Million) Table 274. Iran Praziquantel Revenue (2021-2032) & (US$ Million) Table 275. Egypt Praziquantel Revenue (2021-2032) & (US$ Million) Table 276. Key Raw Materials Table 277. Raw Materials Key Suppliers Table 278. Praziquantel Distributors List Table 279. Praziquantel Customers List Table 280. Research Programs/Design for This Report Table 281. Authors List of This Report Table 282. Secondary Sources Table 283. Primary Sources List of Figures Figure 1. Praziquantel Image Figure 2. Global Praziquantel Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Praziquantel Market Size Share 2021 VS 2025 VS 2032 Figure 4. Patent Image Figure 5. Generic Image Figure 6. Global Praziquantel Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Praziquantel Market Size Share 2021 VS 2025 VS 2032 Figure 8. Liver Fluke Infection Image Figure 9. Cysticercosis Image Figure 10. Cestode Infections Image Figure 11. Trematode Infections Image Figure 12. Schistosoma Infection Image Figure 13. Others Image Figure 14. Global Praziquantel Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Praziquantel Revenue (2021-2032) & (US$ Million) Figure 16. Global Praziquantel Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Praziquantel Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Praziquantel Revenue Market Share by Region (2021-2032) Figure 19. Global Praziquantel Sales (2021-2032) & (K Units) Figure 20. Global Praziquantel Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Praziquantel Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Praziquantel Sales YoY (2021-2032) & (K Units) Figure 23. Europe Praziquantel Sales YoY (2021-2032) & (K Units) Figure 24. China Praziquantel Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Praziquantel Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Praziquantel Sales YoY (2021-2032) & (K Units) Figure 27. Global Praziquantel Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Praziquantel Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Praziquantel Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Praziquantel Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Praziquantel Revenue Market Share by Type (2021-2032) Figure 33. Global Praziquantel Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Praziquantel Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Praziquantel Sales Market Share by Type (2021-2032) Figure 36. Global Praziquantel Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Praziquantel Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Praziquantel Revenue Market Share by Application (2021-2032) Figure 39. Global Praziquantel Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Praziquantel Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Praziquantel Sales Market Share by Application (2021-2032) Figure 42. North America Praziquantel Revenue Share by Type (2021-2032) Figure 43. North America Praziquantel Sales Share by Type (2021-2032) Figure 44. North America Praziquantel Revenue Share by Application (2021-2032) Figure 45. North America Praziquantel Sales Share by Application (2021-2032) Figure 46. North America Praziquantel Revenue Share by Country (2021-2032) Figure 47. North America Praziquantel Sales Share by Country (2021-2032) Figure 48. Europe Praziquantel Revenue Share by Type (2021-2032) Figure 49. Europe Praziquantel Sales Share by Type (2021-2032) Figure 50. Europe Praziquantel Revenue Share by Application (2021-2032) Figure 51. Europe Praziquantel Sales Share by Application (2021-2032) Figure 52. Europe Praziquantel Revenue Share by Country (2021-2032) Figure 53. Europe Praziquantel Sales Share by Country (2021-2032) Figure 54. China Praziquantel Revenue Share by Type (2021-2032) Figure 55. China Praziquantel Sales Share by Type (2021-2032) Figure 56. China Praziquantel Revenue Share by Application (2021-2032) Figure 57. China Praziquantel Sales Share by Application (2021-2032) Figure 58. Asia Praziquantel Revenue Share by Type (2021-2032) Figure 59. Asia Praziquantel Sales Share by Type (2021-2032) Figure 60. Asia Praziquantel Revenue Share by Application (2021-2032) Figure 61. Asia Praziquantel Sales Share by Application (2021-2032) Figure 62. Asia Praziquantel Revenue Share by Country (2021-2032) Figure 63. Asia Praziquantel Sales Share by Country (2021-2032) Figure 64. SAMEA Praziquantel Revenue Share by Type (2021-2032) Figure 65. SAMEA Praziquantel Sales Share by Type (2021-2032) Figure 66. SAMEA Praziquantel Revenue Share by Application (2021-2032) Figure 67. SAMEA Praziquantel Sales Share by Application (2021-2032) Figure 68. SAMEA Praziquantel Revenue Share by Country (2021-2032) Figure 69. SAMEA Praziquantel Sales Share by Country (2021-2032) Figure 70. Praziquantel Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Praziquantel Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • Liver Fluke Infection
  • Cysticercosis
  • Cestode Infections
  • Trematode Infections
  • Schistosoma Infection
  • Others
Companies covered
  • Zoetis
  • Merck
  • Bayer
  • Soparfin
  • Shin Poong Pharm
  • Richter Pharma
  • Norbrook Laboratories
  • Merial
  • Mavlab Animal Health
  • Lavet Pharmaceuticals
  • Kyron Pharma
  • Krka
  • Ecuphar
  • Covetrus
  • CiplaVet
  • Chanelle Pharma
  • Ceva Santé Animale
  • C and H Generics
  • Auvex
  • AniMedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Praziquantel Market by Type
  3. 1.2.1 Global Praziquantel Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Patent
  5. 1.2.3 Generic
  6. 1.3 Praziquantel Market by Application
  7. 1.3.1 Global Praziquantel Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Liver Fluke Infection
  9. 1.3.3 Cysticercosis
  10. 1.3.4 Cestode Infections
  11. 1.3.5 Trematode Infections
  12. 1.3.6 Schistosoma Infection
  13. 1.3.7 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Praziquantel Market Dynamics
  1. 2.1 Praziquantel Industry Trends
  2. 2.2 Praziquantel Industry Drivers
  3. 2.3 Praziquantel Industry Opportunities and Challenges
  4. 2.4 Praziquantel Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Praziquantel Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Praziquantel Revenue by Region
  3. 3.2.1 Global Praziquantel Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Praziquantel Revenue by Region (2021-2026)
  5. 3.2.3 Global Praziquantel Revenue by Region (2027-2032)
  6. 3.2.4 Global Praziquantel Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Praziquantel Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Praziquantel Sales by Region
  9. 3.4.1 Global Praziquantel Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Praziquantel Sales by Region (2021-2026)
  11. 3.4.3 Global Praziquantel Sales by Region (2027-2032)
  12. 3.4.4 Global Praziquantel Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Praziquantel Revenue by Manufacturers
  2. 4.1.1 Global Praziquantel Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Praziquantel Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Praziquantel Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Praziquantel Sales by Manufacturers
  6. 4.2.1 Global Praziquantel Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Praziquantel Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Praziquantel Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Praziquantel Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Praziquantel Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Praziquantel Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Praziquantel Manufacturers, Product Type & Application
  13. 4.7 Global Praziquantel Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Praziquantel Market CR5 and HHI
  16. 4.8.2 2025 Praziquantel Tier 1, Tier 2, and Tier 3
5 Praziquantel Market by Type
  1. 5.1 Global Praziquantel Revenue by Type
  2. 5.1.1 Global Praziquantel Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Praziquantel Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Praziquantel Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Praziquantel Sales by Type
  6. 5.2.1 Global Praziquantel Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Praziquantel Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Praziquantel Sales Market Share by Type (2021-2032)
  9. 5.3 Global Praziquantel Price by Type
6 Praziquantel Market by Application
  1. 6.1 Global Praziquantel Revenue by Application
  2. 6.1.1 Global Praziquantel Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Praziquantel Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Praziquantel Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Praziquantel Sales by Application
  6. 6.2.1 Global Praziquantel Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Praziquantel Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Praziquantel Sales Market Share by Application (2021-2032)
  9. 6.3 Global Praziquantel Price by Application
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Praziquantel Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Praziquantel Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Praziquantel Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Soparfin
  20. 7.4.1 Soparfin Company Information
  21. 7.4.2 Soparfin Business Overview
  22. 7.4.3 Soparfin Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Soparfin Praziquantel Product Portfolio
  24. 7.4.5 Soparfin Recent Developments
  25. 7.5 Shin Poong Pharm
  26. 7.5.1 Shin Poong Pharm Company Information
  27. 7.5.2 Shin Poong Pharm Business Overview
  28. 7.5.3 Shin Poong Pharm Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shin Poong Pharm Praziquantel Product Portfolio
  30. 7.5.5 Shin Poong Pharm Recent Developments
  31. 7.6 Richter Pharma
  32. 7.6.1 Richter Pharma Company Information
  33. 7.6.2 Richter Pharma Business Overview
  34. 7.6.3 Richter Pharma Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Richter Pharma Praziquantel Product Portfolio
  36. 7.6.5 Richter Pharma Recent Developments
  37. 7.7 Norbrook Laboratories
  38. 7.7.1 Norbrook Laboratories Company Information
  39. 7.7.2 Norbrook Laboratories Business Overview
  40. 7.7.3 Norbrook Laboratories Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Norbrook Laboratories Praziquantel Product Portfolio
  42. 7.7.5 Norbrook Laboratories Recent Developments
  43. 7.8 Merial
  44. 7.8.1 Merial Company Information
  45. 7.8.2 Merial Business Overview
  46. 7.8.3 Merial Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Merial Praziquantel Product Portfolio
  48. 7.8.5 Merial Recent Developments
  49. 7.9 Mavlab Animal Health
  50. 7.9.1 Mavlab Animal Health Company Information
  51. 7.9.2 Mavlab Animal Health Business Overview
  52. 7.9.3 Mavlab Animal Health Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mavlab Animal Health Praziquantel Product Portfolio
  54. 7.9.5 Mavlab Animal Health Recent Developments
  55. 7.10 Lavet Pharmaceuticals
  56. 7.10.1 Lavet Pharmaceuticals Company Information
  57. 7.10.2 Lavet Pharmaceuticals Business Overview
  58. 7.10.3 Lavet Pharmaceuticals Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lavet Pharmaceuticals Praziquantel Product Portfolio
  60. 7.10.5 Lavet Pharmaceuticals Recent Developments
  61. 7.11 Kyron Pharma
  62. 7.11.1 Kyron Pharma Company Information
  63. 7.11.2 Kyron Pharma Business Overview
  64. 7.11.3 Kyron Pharma Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Kyron Pharma Praziquantel Product Portfolio
  66. 7.11.5 Kyron Pharma Recent Developments
  67. 7.12 Krka
  68. 7.12.1 Krka Company Information
  69. 7.12.2 Krka Business Overview
  70. 7.12.3 Krka Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Krka Praziquantel Product Portfolio
  72. 7.12.5 Krka Recent Developments
  73. 7.13 Ecuphar
  74. 7.13.1 Ecuphar Company Information
  75. 7.13.2 Ecuphar Business Overview
  76. 7.13.3 Ecuphar Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Ecuphar Praziquantel Product Portfolio
  78. 7.13.5 Ecuphar Recent Developments
  79. 7.14 Covetrus
  80. 7.14.1 Covetrus Company Information
  81. 7.14.2 Covetrus Business Overview
  82. 7.14.3 Covetrus Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Covetrus Praziquantel Product Portfolio
  84. 7.14.5 Covetrus Recent Developments
  85. 7.15 CiplaVet
  86. 7.15.1 CiplaVet Company Information
  87. 7.15.2 CiplaVet Business Overview
  88. 7.15.3 CiplaVet Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 CiplaVet Praziquantel Product Portfolio
  90. 7.15.5 CiplaVet Recent Developments
  91. 7.16 Chanelle Pharma
  92. 7.16.1 Chanelle Pharma Company Information
  93. 7.16.2 Chanelle Pharma Business Overview
  94. 7.16.3 Chanelle Pharma Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Chanelle Pharma Praziquantel Product Portfolio
  96. 7.16.5 Chanelle Pharma Recent Developments
  97. 7.17 Ceva Santé Animale
  98. 7.17.1 Ceva Santé Animale Company Information
  99. 7.17.2 Ceva Santé Animale Business Overview
  100. 7.17.3 Ceva Santé Animale Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Ceva Santé Animale Praziquantel Product Portfolio
  102. 7.17.5 Ceva Santé Animale Recent Developments
  103. 7.18 C and H Generics
  104. 7.18.1 C and H Generics Company Information
  105. 7.18.2 C and H Generics Business Overview
  106. 7.18.3 C and H Generics Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 C and H Generics Praziquantel Product Portfolio
  108. 7.18.5 C and H Generics Recent Developments
  109. 7.19 Auvex
  110. 7.19.1 Auvex Company Information
  111. 7.19.2 Auvex Business Overview
  112. 7.19.3 Auvex Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Auvex Praziquantel Product Portfolio
  114. 7.19.5 Auvex Recent Developments
  115. 7.20 AniMedica
  116. 7.20.1 AniMedica Company Information
  117. 7.20.2 AniMedica Business Overview
  118. 7.20.3 AniMedica Praziquantel Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 AniMedica Praziquantel Product Portfolio
  120. 7.20.5 AniMedica Recent Developments
8 North America
  1. 8.1 North America Praziquantel Market Size by Type
  2. 8.1.1 North America Praziquantel Revenue by Type (2021-2032)
  3. 8.1.2 North America Praziquantel Sales by Type (2021-2032)
  4. 8.1.3 North America Praziquantel Price by Type (2021-2032)
  5. 8.2 North America Praziquantel Market Size by Application
  6. 8.2.1 North America Praziquantel Revenue by Application (2021-2032)
  7. 8.2.2 North America Praziquantel Sales by Application (2021-2032)
  8. 8.2.3 North America Praziquantel Price by Application (2021-2032)
  9. 8.3 North America Praziquantel Market Size by Country
  10. 8.3.1 North America Praziquantel Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Praziquantel Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Praziquantel Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Praziquantel Market Size by Type
  2. 9.1.1 Europe Praziquantel Revenue by Type (2021-2032)
  3. 9.1.2 Europe Praziquantel Sales by Type (2021-2032)
  4. 9.1.3 Europe Praziquantel Price by Type (2021-2032)
  5. 9.2 Europe Praziquantel Market Size by Application
  6. 9.2.1 Europe Praziquantel Revenue by Application (2021-2032)
  7. 9.2.2 Europe Praziquantel Sales by Application (2021-2032)
  8. 9.2.3 Europe Praziquantel Price by Application (2021-2032)
  9. 9.3 Europe Praziquantel Market Size by Country
  10. 9.3.1 Europe Praziquantel Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Praziquantel Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Praziquantel Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Praziquantel Market Size by Type
  2. 10.1.1 China Praziquantel Revenue by Type (2021-2032)
  3. 10.1.2 China Praziquantel Sales by Type (2021-2032)
  4. 10.1.3 China Praziquantel Price by Type (2021-2032)
  5. 10.2 China Praziquantel Market Size by Application
  6. 10.2.1 China Praziquantel Revenue by Application (2021-2032)
  7. 10.2.2 China Praziquantel Sales by Application (2021-2032)
  8. 10.2.3 China Praziquantel Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Praziquantel Market Size by Type
  2. 11.1.1 Asia Praziquantel Revenue by Type (2021-2032)
  3. 11.1.2 Asia Praziquantel Sales by Type (2021-2032)
  4. 11.1.3 Asia Praziquantel Price by Type (2021-2032)
  5. 11.2 Asia Praziquantel Market Size by Application
  6. 11.2.1 Asia Praziquantel Revenue by Application (2021-2032)
  7. 11.2.2 Asia Praziquantel Sales by Application (2021-2032)
  8. 11.2.3 Asia Praziquantel Price by Application (2021-2032)
  9. 11.3 Asia Praziquantel Market Size by Country
  10. 11.3.1 Asia Praziquantel Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Praziquantel Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Praziquantel Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Praziquantel Market Size by Type
  2. 12.1.1 SAMEA Praziquantel Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Praziquantel Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Praziquantel Price by Type (2021-2032)
  5. 12.2 SAMEA Praziquantel Market Size by Application
  6. 12.2.1 SAMEA Praziquantel Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Praziquantel Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Praziquantel Price by Application (2021-2032)
  9. 12.3 SAMEA Praziquantel Market Size by Country
  10. 12.3.1 SAMEA Praziquantel Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Praziquantel Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Praziquantel Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Praziquantel Value Chain Analysis
  2. 13.1.1 Praziquantel Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Praziquantel Production Mode & Process
  6. 13.2 Praziquantel Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Praziquantel Distributors
  9. 13.2.3 Praziquantel Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst